WARREN, N.J., Oct. 25, 2016 /PRNewswire/ -- Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focusedon providing advanced testing solutions for the detection of foodborne pathogens, announced today that Mary Duseau and Lars Boesgaard will be presenting on behalf of the company at the Sidoti
Event: Sidoti & Company Fall 2016 Emerging Growth Convention When: Tuesday, November 1, 2016 Where: New York Marriott Marquis 5th Floor 1535 Broadway, New York, NY 10036
The company is scheduled to deliver a presentation at 3:00pm EDT. Investors interested in attending and scheduling a one-on-one meeting with management should click the link here
About the Sidoti & Company Emerging Growth Convention: The Sidoti & Company Fall 2016 Emerging Growth Convention will focus on companies with market capitalizations of $600 million and less, connecting their executive management teams with institutional and high-net-worth investors while building interest and visibility into the most overlooked, undervalued segment of the equity market.
About Sidoti & Company, LLC: Sidoti & Company, founded in 1999, is Wall Street's preeminent provider of equity research generally focused on companies with market capitalizations of under $3 billion. Sidoti & Company's approach affords institutional investor clients a combination of high-quality research of over 250 companies, a small- and micro-cap company focused nationwide sales effort, broad access to corporate management teams, and extensive trading support. Sidoti & Company serves nearly 500 institutional clients in the U.S., Canada and the U.K., including many leading managers of portfolios with $200 million to $2 billion of assets. They also host a biannual Emerging Growth Convention in New York, and is a provider of company sponsored research. For more information, please refer to Sidoti & Company
About Roka Bioscience Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our "sample-in, result-out" Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. For more information, visit http://rokabio.com.
Investor Contact: Roka Bioscience, Inc. [email protected] 855-ROKABIO (855-765-2246)
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roka-bioscience-to-present-at-the-sidoti--company-fall-2016-emerging-growth-convention-300351049.html
SOURCE Roka Bioscience, Inc.
Subscribe to our Free Newsletters!
Sedentary lifestyle is one that has very little or no physical activity at all, whether at work or ...
Ovarian cancer refers to cancer of ovaries. It is called the "Silent killer", as it is difficult to ...
Schizoaffective disorder is a serious mental disorder in which the individual reflects symptoms ...View All